Connexin and Pannexin (Hemi)Channels: Emerging Targets in the Treatment of Liver Disease-Reference-Cited by-同舟云学术

Connexin and Pannexin (Hemi)Channels: Emerging Targets in the Treatment of Liver Disease

Author:

Cooreman Axelle¹,Van Campenhout Raf¹,Ballet Steven²,Annaert Pieter³,Van Den Bossche Bert⁴,Colle Isabelle⁵,Cogliati Bruno⁶,Vinken Mathieu¹

Affiliation:

1. Department of Toxicology; Vrije Universiteit Brussel; Brussels Belgium

2. Research Group of Organic Chemistry, Departments of Chemistry and Bioengineering Sciences; Vrije Universiteit Brussel; Brussels Belgium

3. Drug Delivery and Disposition, KU Leuven Department of Pharmaceutical and Pharmacological Sciences; Leuven Belgium

4. Department of Abdominal Surgery and Hepato-Pancreatico-Biliary Surgery; Algemeen Stedelijk Ziekenhuis Campus Aalst; Aalst Belgium

5. Department of Hepatology and Gastroenterology; Algemeen Stedelijk Ziekenhuis Campus Aalst; Aalst Belgium

6. Department of Pathology, School of Veterinary Medicine and Animal Science; University of São Paulo; São Paulo Brazil

Funder

Sao Paulo Research Foundation

H2020 European Research Council

Fund for Scientific Research Flanders-Belgium

University Hospital of the Vrije Universiteit Brussel-Belgium

Fundação de Amparo à Pesquisa do Estado de São Paulo

Publisher

Wiley

Subject

Hepatology

Link

Reference53 articles.

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

5. Pannexin1 channels in the liver: an open enemy;Frontiers in Cell and Developmental Biology;2023-07-10